首页 > 最新文献

"Medical & pharmaceutical journal "Pulse"最新文献

英文 中文
SAFETY OF MEDICAL ACTIVITY IN DENTISTRY 牙科医疗活动的安全
Pub Date : 2021-09-11 DOI: 10.26787/nydha-2686-6838-2021-23-9-183-190
Andreeva S.N., Furchakova A.V.
Today, ensuring the safety of patients and medical personnel is an integral part of medical practice. In dentistry, this problem is especially relevant, given the fact that dentists occupy one of the leading places in terms of the frequency of professional errors among doctors who have been sued, as well as the frequency of complaints from patients about the quality of medical care. This article discusses the safety of medical activities and the safety of medical care in medical organizations, in general, and in dentistry in particular, an analysis of the regulatory documentation in relation to these concepts is carried out, and issues of terminology are considered. Analysis of literary sources shows that today there is uncertainty in the interpretation of the concept of "safety of medical activity" due to the lack of a legislatively enshrined definition of this concept. With regard to dental practice, the safety of medical activities includes the safety of the patient, the safety of medical personnel, the safety of the environment in which dental care is provided, as well as the safety of pharmaceuticals and medical dental equipment. Organizational, legal, personnel and economic security can also be considered as constituent parts of the safety of medical activities. At the same time, there is no unambiguous understanding of the relationships between the concepts of safety of medical activity, safety of medical care, safety of medical services, safety of the medical environment. An important unresolved to date task is to determine the criteria for assessing the safety of medical activities. Taking into account the versatility of the concept of the safety of medical activities and the specifics of medical activities, it is necessary to develop criteria for assessing the safety of medical activities for each specialty, including dentistry. It seems that the assessment structure should be uniform for all medical activities, but include specific elements with criteria for the safety of medical activities in individual specialties.
今天,确保病人和医务人员的安全是医疗实践的一个组成部分。在牙科领域,这个问题尤其重要,因为在被起诉的医生中,牙医的职业失误频率最高,病人对医疗质量的投诉频率也最高。本文讨论了医疗活动的安全性和医疗机构的医疗安全,一般来说,特别是在牙科领域,对与这些概念相关的监管文件进行了分析,并考虑了术语问题。对文献资料的分析表明,今天对“医疗活动安全”概念的解释存在不确定性,因为缺乏对这一概念的立法规定。关于牙科执业,医疗活动的安全包括病人的安全、医务人员的安全、提供牙科护理的环境的安全,以及药品和医疗牙科设备的安全。组织、法律、人员和经济安全也可视为医疗活动安全的组成部分。同时,对医疗活动安全、医疗护理安全、医疗服务安全、医疗环境安全等概念之间的关系也没有明确的认识。迄今尚未解决的一项重要任务是确定评估医疗活动安全的标准。考虑到医疗活动安全概念的多样性和医疗活动的特殊性,有必要为包括牙科在内的每个专业制定评估医疗活动安全的标准。似乎所有医疗活动的评估结构应该是统一的,但应包括个别专业医疗活动安全的具体要素和标准。
{"title":"SAFETY OF MEDICAL ACTIVITY IN DENTISTRY","authors":"Andreeva S.N., Furchakova A.V.","doi":"10.26787/nydha-2686-6838-2021-23-9-183-190","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-9-183-190","url":null,"abstract":"Today, ensuring the safety of patients and medical personnel is an integral part of medical practice. In dentistry, this problem is especially relevant, given the fact that dentists occupy one of the leading places in terms of the frequency of professional errors among doctors who have been sued, as well as the frequency of complaints from patients about the quality of medical care. This article discusses the safety of medical activities and the safety of medical care in medical organizations, in general, and in dentistry in particular, an analysis of the regulatory documentation in relation to these concepts is carried out, and issues of terminology are considered. Analysis of literary sources shows that today there is uncertainty in the interpretation of the concept of \"safety of medical activity\" due to the lack of a legislatively enshrined definition of this concept. With regard to dental practice, the safety of medical activities includes the safety of the patient, the safety of medical personnel, the safety of the environment in which dental care is provided, as well as the safety of pharmaceuticals and medical dental equipment. Organizational, legal, personnel and economic security can also be considered as constituent parts of the safety of medical activities. At the same time, there is no unambiguous understanding of the relationships between the concepts of safety of medical activity, safety of medical care, safety of medical services, safety of the medical environment. An important unresolved to date task is to determine the criteria for assessing the safety of medical activities. Taking into account the versatility of the concept of the safety of medical activities and the specifics of medical activities, it is necessary to develop criteria for assessing the safety of medical activities for each specialty, including dentistry. It seems that the assessment structure should be uniform for all medical activities, but include specific elements with criteria for the safety of medical activities in individual specialties.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125385856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LEVISTICUM OFFICINALE (F. APIACEAE): HABITAT, BOTANICAL DESCRIPTION AND CHEMICAL COMPOSITION (REVIEW) officinale (f. apiaceae):生境、植物描述和化学成分(综述)
Pub Date : 2021-09-11 DOI: 10.26787/nydha-2686-6838-2021-23-9-67-75
Kubasova E.D., Korelskaya G.V., Kubasov R.V.
The Medicinal Lovage (Levisticum Officinale) grows almost everywhere. In order to use Levisticum Officinale in economic needs, including in medicine, a number of countries are specially engaged in its cultivation. The analysis of the scientific literature revealed a large number of publications confirming the diverse chemical spectrum of rhizomes, roots and herbs of the medicinal lovage. In this regard, it is used as a medicinal raw material and is included in a number of European Pharmacopoeias. For medical purposes, all parts of this plant that contain biologically active substances can be used. Levisticum officinale contains various phytochemical compounds and secondary metabolites – terpenoids, flavonoids, essential oils, phthalides, polyacetylenes, coumarins, phenylpropanoids, alkaloids, tannins, phenolic acids, polyacetylenes. All of them have properties that can have a therapeutic effect on the organism. The composition of essential oils of Levisticum Officinale is the most studied. It is mainly represented by monoterpene hydrocarbons, sexwiterpenes and phthalides. There are some differences in the chemical composition of Levisticum Officinale. Most scientists agree that such a discrepancy may be related to the period and process of harvesting plant raw materials, age, genotype of the plant, climatic conditions and place of growth, as well as the method of extraction and the method of identification and quantitative determination of biologically active substances. Therefore, there is a problem of a single universal system of preparation and further use of raw materials. The development of modern methods for analyzing the raw materials of lovage and the study of its chemical composition creates prerequisites for expanding its use as a medicinal plant.
药用野蔷薇(Levisticum Officinale)几乎到处都生长。为了在包括医药在内的经济需要中使用牛蒡,一些国家专门从事其种植。通过对科学文献的分析,发现了大量的出版物,证实了药用牧草的根茎、根和草药的化学光谱的多样性。在这方面,它被用作药用原料,并被列入许多欧洲药典。出于医疗目的,这种植物含有生物活性物质的所有部分都可以使用。officinale含有多种植物化学化合物和次生代谢物——萜类、类黄酮、精油、酞、聚乙炔、香豆素、苯丙素、生物碱、单宁、酚酸、聚乙炔。它们都具有对机体有治疗作用的特性。Officinale的精油成分是研究最多的。主要以单萜烃、六萜烯和邻苯酞为代表。Officinale的用法和目的:Officinale的用法和目的:大多数科学家认为,这种差异可能与植物原料的采伐时间和过程、植物的年龄、基因型、气候条件和生长地点以及提取方法和生物活性物质的鉴定和定量测定方法有关。因此,存在原料制备和进一步利用的单一通用系统的问题。现代草药原料分析方法的发展及其化学成分的研究为扩大其作为药用植物的使用创造了先决条件。
{"title":"LEVISTICUM OFFICINALE (F. APIACEAE): HABITAT, BOTANICAL DESCRIPTION AND CHEMICAL COMPOSITION (REVIEW)","authors":"Kubasova E.D., Korelskaya G.V., Kubasov R.V.","doi":"10.26787/nydha-2686-6838-2021-23-9-67-75","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-9-67-75","url":null,"abstract":"The Medicinal Lovage (Levisticum Officinale) grows almost everywhere. In order to use Levisticum Officinale in economic needs, including in medicine, a number of countries are specially engaged in its cultivation. The analysis of the scientific literature revealed a large number of publications confirming the diverse chemical spectrum of rhizomes, roots and herbs of the medicinal lovage. In this regard, it is used as a medicinal raw material and is included in a number of European Pharmacopoeias. For medical purposes, all parts of this plant that contain biologically active substances can be used. Levisticum officinale contains various phytochemical compounds and secondary metabolites – terpenoids, flavonoids, essential oils, phthalides, polyacetylenes, coumarins, phenylpropanoids, alkaloids, tannins, phenolic acids, polyacetylenes. All of them have properties that can have a therapeutic effect on the organism. The composition of essential oils of Levisticum Officinale is the most studied. It is mainly represented by monoterpene hydrocarbons, sexwiterpenes and phthalides. There are some differences in the chemical composition of Levisticum Officinale. Most scientists agree that such a discrepancy may be related to the period and process of harvesting plant raw materials, age, genotype of the plant, climatic conditions and place of growth, as well as the method of extraction and the method of identification and quantitative determination of biologically active substances. Therefore, there is a problem of a single universal system of preparation and further use of raw materials. The development of modern methods for analyzing the raw materials of lovage and the study of its chemical composition creates prerequisites for expanding its use as a medicinal plant.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"96 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124162295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
STUDY OF HEART RATE VARIABILITY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING PROPHYLACTIC TREATMENT OF METOPROLOL AND CORDARONE FOR ONE YEAR 阵发性心房颤动患者预防性使用美托洛尔和可达酮一年期间心率变异性的研究
Pub Date : 2021-09-11 DOI: 10.26787/nydha-2686-6838-2021-23-9-128-135
Rybakova T.A., Stolyarov V.V., Gizova M.V.
This work is devoted to the dynamic study of heart rate variability indicators for one year in patients with paroxysmal atrial fibrillation treated with antiarrhythmic drugs metoprolol and cordarone. The study found that patients treated with metoprolol monotherapy had a weakening of parasympathetic effects on the heart, due to a decrease in Mean by 12.9%, Mo by 13%, Amo by 29.4%, SDNN by 28.3% compared to the group of healthy individuals, but they differed in stable indicators of heart rate variability and 33% retained sinus rhythm during the year. With cordarone monotherapy, there was a curative effect of sympathetic and parasympathetic effects on the heart, as indicated by an increase in: Mean by 15.9%, Mo by 15.9%, IVR by 95.5%, Amo by 41.1% and a decrease in SDNN by 37.5%, compared with the group of healthy individuals at the initial stage. A year later, a negative dynamics was revealed - the predominance of sympathetic influences on the heart compared to the groups of healthy individuals and the control due to an increase in: IVR by 363.3% and 238.5%; VPR by 116.7% and 106%; Amo by 111.2% and 72.9; IN by 304% and 246.8%; PAPR by 92% and 79.1%, respectively. During the year, 39% of patients left the study due to the replacement of antiarrhythmic therapy and 16.5% due to the development of a permanent form of atrial fibrillation. In the remaining patients in the study, in comparison with their initial data, there was a predominance of sympathetic effects on the heart due to an increase in IVR by 137%. In combination therapy with metoprolol and cordarone, there were no significant changes in heart rate variability compared to the initial ones. Initially, there was a decrease in overall heart rate variability due to a decrease in SDNN by 28.4% and a decrease in parasympathetic effects on the heart due to an increase in Amo by 45.2% and a decrease in Delta X by 32.9% compared to the group of healthy individuals. After a year, 40% left the study due to the replacement of antiarrhythmic therapy and 30% due to the development of a permanent form of atrial fibrillation. During dynamic observation of patients, it was found that the following indicators have the most important prognostic value in the development of atrial fibrillation: SDNN, Delta X and RMSSD. Therefore, it is very important to register an ECG with the measurement of these indicators at least once every 3 months for timely correction of treatment.
本研究对阵发性心房颤动患者使用抗心律失常药物美托洛尔和可达酮治疗一年的心率变异性指标进行动态研究。研究发现,接受美托洛尔单药治疗的患者对心脏的副交感神经作用减弱,与健康个体组相比,Mean下降12.9%,Mo下降13%,Amo下降29.4%,SDNN下降28.3%,但在心率变异性的稳定指标上存在差异,33%的患者全年保持窦性心律。柯达酮单药治疗对心脏交感和副交感神经的疗效,与健康组相比,Mean增加15.9%,Mo增加15.9%,IVR增加95.5%,Amo增加41.1%,SDNN减少37.5%。一年后,一种消极的动态被揭示出来——与健康个体和对照组相比,交感神经对心脏的影响占主导地位,原因是:IVR增加了363.3%和238.5%;VPR分别为116.7%和106%;Amo分别增长111.2%和72.9%;IN分别增长304%和246.8%;PAPR分别提高了92%和79.1%。在这一年中,39%的患者因更换抗心律失常治疗而退出研究,16.5%的患者因发生永久性心房颤动而退出研究。在研究的其余患者中,与他们的初始数据相比,由于IVR增加了137%,对心脏的交感作用占主导地位。在美托洛尔和可达酮联合治疗中,与初始治疗相比,心率变异性没有明显变化。最初,与健康个体相比,由于SDNN减少了28.4%,总体心率变异性降低,由于Amo增加了45.2%,Delta X减少了32.9%,副交感神经对心脏的影响降低。一年后,40%的人因更换抗心律失常治疗而退出研究,30%的人因永久性房颤的发展而退出研究。在对患者的动态观察中,发现以下指标对房颤的发展具有最重要的预后价值:SDNN、Delta X和RMSSD。因此,至少每3个月记录一次这些指标的心电图,以便及时纠正治疗是非常重要的。
{"title":"STUDY OF HEART RATE VARIABILITY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING PROPHYLACTIC TREATMENT OF METOPROLOL AND CORDARONE FOR ONE YEAR","authors":"Rybakova T.A., Stolyarov V.V., Gizova M.V.","doi":"10.26787/nydha-2686-6838-2021-23-9-128-135","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-9-128-135","url":null,"abstract":"This work is devoted to the dynamic study of heart rate variability indicators for one year in patients with paroxysmal atrial fibrillation treated with antiarrhythmic drugs metoprolol and cordarone. The study found that patients treated with metoprolol monotherapy had a weakening of parasympathetic effects on the heart, due to a decrease in Mean by 12.9%, Mo by 13%, Amo by 29.4%, SDNN by 28.3% compared to the group of healthy individuals, but they differed in stable indicators of heart rate variability and 33% retained sinus rhythm during the year. With cordarone monotherapy, there was a curative effect of sympathetic and parasympathetic effects on the heart, as indicated by an increase in: Mean by 15.9%, Mo by 15.9%, IVR by 95.5%, Amo by 41.1% and a decrease in SDNN by 37.5%, compared with the group of healthy individuals at the initial stage. A year later, a negative dynamics was revealed - the predominance of sympathetic influences on the heart compared to the groups of healthy individuals and the control due to an increase in: IVR by 363.3% and 238.5%; VPR by 116.7% and 106%; Amo by 111.2% and 72.9; IN by 304% and 246.8%; PAPR by 92% and 79.1%, respectively. During the year, 39% of patients left the study due to the replacement of antiarrhythmic therapy and 16.5% due to the development of a permanent form of atrial fibrillation. In the remaining patients in the study, in comparison with their initial data, there was a predominance of sympathetic effects on the heart due to an increase in IVR by 137%. In combination therapy with metoprolol and cordarone, there were no significant changes in heart rate variability compared to the initial ones. Initially, there was a decrease in overall heart rate variability due to a decrease in SDNN by 28.4% and a decrease in parasympathetic effects on the heart due to an increase in Amo by 45.2% and a decrease in Delta X by 32.9% compared to the group of healthy individuals. After a year, 40% left the study due to the replacement of antiarrhythmic therapy and 30% due to the development of a permanent form of atrial fibrillation. During dynamic observation of patients, it was found that the following indicators have the most important prognostic value in the development of atrial fibrillation: SDNN, Delta X and RMSSD. Therefore, it is very important to register an ECG with the measurement of these indicators at least once every 3 months for timely correction of treatment.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132019122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
ANTIPLATELET THERAPY AND SECONDARY PROPHYLAXIS AFTER CORONARY BYPASS SURGERY IN ACUTE CORONARY SYNDROME 急性冠脉综合征冠状动脉搭桥术后抗血小板治疗及二级预防
Pub Date : 2021-09-11 DOI: 10.26787/nydha-2686-6838-2021-23-9-45-51
Jalilov A.K., I. R.G.
Antiplatelet therapy with aspirin and clopidogrel has clear advantages in reducing serious adverse cardiovascular events and mortality following acute coronary syndrome. Although these drugs may pose an additional risk of bleeding in the small percentage of acute coronary syndrome patients who will undergo coronary artery bypass grafting, the benefits are vastly superior, and most bleeding can be reduced, if possible, by delaying coronary artery bypass grafting. Short-acting anticoagulants can be administered flexibly, allowing platelet function to be restored after clopidogrel is discontinued. The postoperative bleeding time may clarify the need for platelet transfusion in case of bleeding. Coronary artery bypass grafting without the use of a heart-lung machine may offer some benefits by avoiding heparinization and the inflammatory response associated with bypass surgery. Secondary prophylaxis with antiplatelet therapy, beta-blockers, lipid-lowering therapy, and ACE inhibitors or angiotensin-converting enzyme inhibitors is critical to the long-term success of revascularization. In this regard, it should be borne in mind that regardless of the method of revascularization, patients with acute coronary syndrome are characterized by the clinical benefit of taking antiplatelet agents such as aspirin and clopidogrel, since these drugs reduce the risk of serious adverse events. On the other hand, antiplatelet agents also increase the risk of bleeding in patients who will eventually undergo coronary artery bypass grafting. However, scientists indicate that in most cases, the benefits of early initiation of antiplatelet therapy outweigh the potential risks [1]. In addition, the beneficial effects of aspirin and clopidogrel in acute coronary syndrome are additive. In the study of clopidogrel, indicated for the prevention of recurrence of unstable angina and non-ST-segment elevation myocardial infarction, patients taking both clopidogrel and aspirin were less likely to die of cardiac death, non-fatal myocardial infarction, or stroke at 30 days and 1 year compared with patients who took only aspirin [22]. All these studies confirm that antiplatelet therapy with aspirin and clopidogrel should be carried out in the early stages of acute coronary syndrome. In patients with ST-segment elevation myocardial infarction, clopidogrel improves outcomes in addition to aspirin. In a trial of clopidogrel and metoprolol for myocardial infarction, clopidogrel, in addition to aspirin, was associated with a significant reduction in death, re-heart attack, or stroke compared with aspirin alone [14].
阿司匹林和氯吡格雷抗血小板治疗在减少急性冠状动脉综合征后的严重不良心血管事件和死亡率方面具有明显的优势。虽然这些药物可能会对一小部分接受冠状动脉旁路移植术的急性冠状动脉综合征患者造成额外的出血风险,但其好处是非常优越的,并且如果可能的话,通过延迟冠状动脉旁路移植术可以减少大多数出血。短效抗凝剂可以灵活使用,在停用氯吡格雷后,可以恢复血小板功能。术后出血时间可以明确出血时是否需要输血小板。不使用心肺机的冠状动脉旁路移植术可以避免肝素化和与旁路手术相关的炎症反应,从而提供一些好处。二级预防包括抗血小板治疗、β受体阻滞剂、降脂治疗、ACE抑制剂或血管紧张素转换酶抑制剂对血管重建术的长期成功至关重要。在这方面,应该记住,无论采用何种方法进行血运重建,急性冠状动脉综合征患者的特点是服用抗血小板药物(如阿司匹林和氯吡格雷)具有临床益处,因为这些药物可以降低严重不良事件的风险。另一方面,抗血小板药物也会增加最终接受冠状动脉旁路移植术的患者出血的风险。然而,科学家指出,在大多数情况下,早期开始抗血小板治疗的益处大于潜在的风险[1]。此外,阿司匹林和氯吡格雷对急性冠脉综合征的有益作用是叠加的。在氯吡格雷用于预防不稳定型心绞痛和非st段抬高型心肌梗死复发的研究中,与仅服用阿司匹林的患者相比,同时服用氯吡格雷和阿司匹林的患者在30天和1年内死于心源性死亡、非致死性心肌梗死或卒中的可能性更低[22]。所有这些研究证实,在急性冠状动脉综合征的早期应进行阿司匹林和氯吡格雷抗血小板治疗。对于st段抬高型心肌梗死患者,除阿司匹林外,氯吡格雷可改善预后。在一项氯吡格雷和美托洛尔联合治疗心肌梗死的试验中,与单独使用阿司匹林相比,氯吡格雷和阿司匹林可显著降低死亡、再次心脏病发作或中风的发生率[14]。
{"title":"ANTIPLATELET THERAPY AND SECONDARY PROPHYLAXIS AFTER CORONARY BYPASS SURGERY IN ACUTE CORONARY SYNDROME","authors":"Jalilov A.K., I. R.G.","doi":"10.26787/nydha-2686-6838-2021-23-9-45-51","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-9-45-51","url":null,"abstract":"Antiplatelet therapy with aspirin and clopidogrel has clear advantages in reducing serious adverse cardiovascular events and mortality following acute coronary syndrome. Although these drugs may pose an additional risk of bleeding in the small percentage of acute coronary syndrome patients who will undergo coronary artery bypass grafting, the benefits are vastly superior, and most bleeding can be reduced, if possible, by delaying coronary artery bypass grafting. Short-acting anticoagulants can be administered flexibly, allowing platelet function to be restored after clopidogrel is discontinued. The postoperative bleeding time may clarify the need for platelet transfusion in case of bleeding. Coronary artery bypass grafting without the use of a heart-lung machine may offer some benefits by avoiding heparinization and the inflammatory response associated with bypass surgery. Secondary prophylaxis with antiplatelet therapy, beta-blockers, lipid-lowering therapy, and ACE inhibitors or angiotensin-converting enzyme inhibitors is critical to the long-term success of revascularization. In this regard, it should be borne in mind that regardless of the method of revascularization, patients with acute coronary syndrome are characterized by the clinical benefit of taking antiplatelet agents such as aspirin and clopidogrel, since these drugs reduce the risk of serious adverse events. On the other hand, antiplatelet agents also increase the risk of bleeding in patients who will eventually undergo coronary artery bypass grafting. However, scientists indicate that in most cases, the benefits of early initiation of antiplatelet therapy outweigh the potential risks [1]. In addition, the beneficial effects of aspirin and clopidogrel in acute coronary syndrome are additive. In the study of clopidogrel, indicated for the prevention of recurrence of unstable angina and non-ST-segment elevation myocardial infarction, patients taking both clopidogrel and aspirin were less likely to die of cardiac death, non-fatal myocardial infarction, or stroke at 30 days and 1 year compared with patients who took only aspirin [22]. All these studies confirm that antiplatelet therapy with aspirin and clopidogrel should be carried out in the early stages of acute coronary syndrome. In patients with ST-segment elevation myocardial infarction, clopidogrel improves outcomes in addition to aspirin. In a trial of clopidogrel and metoprolol for myocardial infarction, clopidogrel, in addition to aspirin, was associated with a significant reduction in death, re-heart attack, or stroke compared with aspirin alone [14].","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"102 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123241352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANALYSIS OF THE AVAILABILITY AND EFFICIENCY OF MEDICAL CARE PROVIDED TO PATIENTS IN THE PROFILE "MEDICAL REHABILITATION" IN ASTRAKHAN REGION 分析阿斯特拉罕地区"医疗康复"概况中向患者提供的医疗服务的可得性和效率
Pub Date : 2021-09-11 DOI: 10.26787/nydha-2686-6838-2021-23-9-23-29
Ermolaev D.O., Ermolaeva Yu.N., Mordovсev N.A.
The relevance of the study due to the need to pay more attention to the effective planning of health care volumes under the compulsory health insurance and the creation of an accessible system of medical rehabilitation for adults in the region. The purpose of the study is to analyze the availability and effectiveness of medical care provided to adults in the "medical rehabilitation" profile within the framework of compulsory medical insurance in the Astrakhan region. Materials and methods - on the basis of data from the Federal State Statistics Service, the territorial fund of compulsory medical insurance in the Astrakhan region, annual reporting statistical forms No. 30, 14, 14-DS, the calculation and analysis of indicators of the optimal volume of medical care for the profile of medical rehabilitation was carried out, taking into account the profile of the disease (the number of hospitalizations per one inhabitant per year, funding per unit of the volume of medical care) of adult patients aged 18 years and older. Results and discussion - the article presents the results of assessing the planned and actual indicators of the volume of medical care for medical rehabilitation for adults, taking into account the profile of diseases in the conditions of round-the-clock and day hospitals of medical organizations participating in the territorial program of state guarantees of free provision of medical care to citizens in the region in 2019. It was revealed that at the expense of the compulsory medical insurance fund, the largest proportion of treated patients in rehabilitation beds is noted among those who receive medical services for neuro- and cardiac rehabilitation. However, rehabilitation care for critically ill patients with scores on the rehabilitation routing scale of 5 and 6 points, with a high rehabilitation potential, as well as for other categories of patients with somatic diseases, remains inaccessible. Conclusion. The obtained research data can be used for further organizational and methodological work to increase the availability and efficiency of medical rehabilitation care for adults, the development of available routing schemes, selection procedures, digitalization of the management of patient flows sent to medical rehabilitation within the framework of compulsory medical insurance at the regional level.
这项研究的相关性在于,需要更多地关注强制性健康保险下的医疗保健量的有效规划,并为该地区的成年人建立一个可获得的医疗康复系统。该研究的目的是分析阿斯特拉罕地区在强制医疗保险框架内向成人提供的"医疗康复"医疗服务的可得性和有效性。材料和方法——根据联邦国家统计局、阿斯特拉罕地区强制性医疗保险基金和第30、14、14- ds号年度报告统计表格提供的数据,计算和分析了医疗康复概况的最佳医疗照护量指标,同时考虑到疾病概况(每年每名居民的住院人数;为18岁及以上成年病人提供的每单位医疗服务的经费。结果和讨论——本文介绍了评估成人医疗康复医疗量的计划和实际指标的结果,同时考虑到2019年参加国家保障向该地区公民免费提供医疗服务的领土方案的医疗机构的24小时和日间医院的疾病概况。据透露,在强制性医疗保险基金的支出下,在康复病床上接受治疗的病人中,接受神经和心脏康复医疗服务的比例最大。然而,对于康复路线评分为5分和6分、康复潜力高的危重患者,以及其他类别的躯体疾病患者,仍然无法获得康复护理。结论。获得的研究数据可用于进一步的组织和方法工作,以提高成人医疗康复护理的可获得性和效率,制定可用的路线计划,选择程序,在区域一级强制医疗保险框架内对送往医疗康复的患者流量进行数字化管理。
{"title":"ANALYSIS OF THE AVAILABILITY AND EFFICIENCY OF MEDICAL CARE PROVIDED TO PATIENTS IN THE PROFILE \"MEDICAL REHABILITATION\" IN ASTRAKHAN REGION","authors":"Ermolaev D.O., Ermolaeva Yu.N., Mordovсev N.A.","doi":"10.26787/nydha-2686-6838-2021-23-9-23-29","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-9-23-29","url":null,"abstract":"The relevance of the study due to the need to pay more attention to the effective planning of health care volumes under the compulsory health insurance and the creation of an accessible system of medical rehabilitation for adults in the region. The purpose of the study is to analyze the availability and effectiveness of medical care provided to adults in the \"medical rehabilitation\" profile within the framework of compulsory medical insurance in the Astrakhan region. Materials and methods - on the basis of data from the Federal State Statistics Service, the territorial fund of compulsory medical insurance in the Astrakhan region, annual reporting statistical forms No. 30, 14, 14-DS, the calculation and analysis of indicators of the optimal volume of medical care for the profile of medical rehabilitation was carried out, taking into account the profile of the disease (the number of hospitalizations per one inhabitant per year, funding per unit of the volume of medical care) of adult patients aged 18 years and older. Results and discussion - the article presents the results of assessing the planned and actual indicators of the volume of medical care for medical rehabilitation for adults, taking into account the profile of diseases in the conditions of round-the-clock and day hospitals of medical organizations participating in the territorial program of state guarantees of free provision of medical care to citizens in the region in 2019. It was revealed that at the expense of the compulsory medical insurance fund, the largest proportion of treated patients in rehabilitation beds is noted among those who receive medical services for neuro- and cardiac rehabilitation. However, rehabilitation care for critically ill patients with scores on the rehabilitation routing scale of 5 and 6 points, with a high rehabilitation potential, as well as for other categories of patients with somatic diseases, remains inaccessible. Conclusion. The obtained research data can be used for further organizational and methodological work to increase the availability and efficiency of medical rehabilitation care for adults, the development of available routing schemes, selection procedures, digitalization of the management of patient flows sent to medical rehabilitation within the framework of compulsory medical insurance at the regional level.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115541143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INFLUENCE OF EARLY TERMINATION OF TREATMENT OF PATIENTS WITH TUBERCULOSIS ON ITS EFFECTIVENESS 肺结核患者早期终止治疗对其疗效的影响
Pub Date : 2021-09-11 DOI: 10.26787/nydha-2686-6838-2021-23-9-136-141
Shurygin A.A., M. E.A.
The effectiveness of a course of chemotherapy largely depends on the continuity and duration. An ineffective outcome of a course of chemotherapy, in addition to objective reasons, also has an additional factor that strengthens it – a break in treatment or its early termination. The aim of the work is to study the effectiveness of treatment of patients with pulmonary tuberculosis with preserved drug sensitivity of the pathogen with early termination of the course of chemotherapy. Materials and methods: A retrospective analysis of the outcomes of a course of chemotherapy of tuberculosis patients who prematurely interrupted treatment, registered for 1-2-3 chemotherapy regimens in the Perm Region, was carried out. Results: Interruptions in treatment or its early termination were present in 7.8% of patients registered for treatment with 1-2-3 chemotherapy regimens. At the stage of inpatient treatment, there is a separation from treatment in 3.5% of patients receiving treatment in the intensive phase of 1-2-3 chemotherapy regimens. Separation from treatment at the outpatient stage is noted in 7.9% of patients receiving treatment in the continuation phase of 1-2-3 chemotherapy regimens, these terms are insufficient for a full course of chemotherapy.. An additional unfavorable factor of intermittent treatment is the formation of secondary drug resistance of Mycobacterium tuberculosis. The ineffectiveness of the course of chemotherapy leads to an increase in the number of patients with tuberculosis and the tension of the epidemic situation. Conclusions: In the treatment of patients with drug-sensitive tuberculosis in the Perm Region, treatment is interrupted more often at the outpatient stage than at the inpatient stage (p=0.03), which requires further study of the reasons for preventing early termination of treatment. It was found that the termination of treatment prematurely in all patients led to the ineffectiveness of CT. Social factors (lack of income, unfavorable living conditions and distance from drug dispensaries, staffing of qualified medical personnel) can affect the adherence and effectiveness of treatment.
化疗疗程的有效性很大程度上取决于疗程的连续性和持续时间。一个疗程化疗的无效结果,除了客观原因外,还有一个因素加强了它——治疗中断或早期终止。本研究旨在探讨早期终止化疗对保留病原菌药敏的肺结核患者的治疗效果。材料和方法:回顾性分析了在彼尔姆地区注册的1-2-3化疗方案中过早中断治疗的结核病患者的化疗过程的结果。结果:采用1-2-3化疗方案的患者中有7.8%出现治疗中断或早期终止。在住院治疗阶段,在1-2-3化疗方案强化阶段接受治疗的患者中有3.5%与治疗分离。在1-2-3化疗方案的继续阶段接受治疗的患者中,有7.9%的患者在门诊阶段与治疗分离,这些术语不足以用于整个化疗过程。间歇性治疗的另一个不利因素是结核分枝杆菌继发性耐药的形成。化疗过程的无效导致结核病患者人数的增加和疫情的紧张。结论:彼尔姆地区药物敏感性结核病患者在治疗中,门诊阶段中断治疗的频率高于住院阶段(p=0.03),预防早期终止治疗的原因有待进一步研究。结果发现,所有患者均因过早终止治疗导致CT无效。社会因素(缺乏收入、不利的生活条件和远离药房、配备合格的医务人员)会影响治疗的坚持性和有效性。
{"title":"INFLUENCE OF EARLY TERMINATION OF TREATMENT OF PATIENTS WITH TUBERCULOSIS ON ITS EFFECTIVENESS","authors":"Shurygin A.A., M. E.A.","doi":"10.26787/nydha-2686-6838-2021-23-9-136-141","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-9-136-141","url":null,"abstract":"The effectiveness of a course of chemotherapy largely depends on the continuity and duration. An ineffective outcome of a course of chemotherapy, in addition to objective reasons, also has an additional factor that strengthens it – a break in treatment or its early termination. The aim of the work is to study the effectiveness of treatment of patients with pulmonary tuberculosis with preserved drug sensitivity of the pathogen with early termination of the course of chemotherapy. Materials and methods: A retrospective analysis of the outcomes of a course of chemotherapy of tuberculosis patients who prematurely interrupted treatment, registered for 1-2-3 chemotherapy regimens in the Perm Region, was carried out. Results: Interruptions in treatment or its early termination were present in 7.8% of patients registered for treatment with 1-2-3 chemotherapy regimens. At the stage of inpatient treatment, there is a separation from treatment in 3.5% of patients receiving treatment in the intensive phase of 1-2-3 chemotherapy regimens. Separation from treatment at the outpatient stage is noted in 7.9% of patients receiving treatment in the continuation phase of 1-2-3 chemotherapy regimens, these terms are insufficient for a full course of chemotherapy.. An additional unfavorable factor of intermittent treatment is the formation of secondary drug resistance of Mycobacterium tuberculosis. The ineffectiveness of the course of chemotherapy leads to an increase in the number of patients with tuberculosis and the tension of the epidemic situation. Conclusions: In the treatment of patients with drug-sensitive tuberculosis in the Perm Region, treatment is interrupted more often at the outpatient stage than at the inpatient stage (p=0.03), which requires further study of the reasons for preventing early termination of treatment. It was found that the termination of treatment prematurely in all patients led to the ineffectiveness of CT. Social factors (lack of income, unfavorable living conditions and distance from drug dispensaries, staffing of qualified medical personnel) can affect the adherence and effectiveness of treatment.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125995783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PATIENT CULTURE AS A FACTOR IN ENSURING THE QUALITY OF MEDICAL CARE 患者文化是确保医疗质量的一个因素
Pub Date : 2021-09-11 DOI: 10.26787/nydha-2686-6838-2021-23-9-106-112
Oleynik A.V., Mushnikov D.L., Germakhanov Z.Z., Drobysheva E.V.
The relevance of the study is due to the insufficient development of improving the structural component of the quality of medical care in terms of the cultural characteristics of the participants in their provision. The purpose of the study: to determine the contribution of the patient's culture factor to ensuring the quality of medical care of different profiles. The collection of material was carried out by the method of sociological survey of patients on the original questionnaires and the method of expert assessment of cases of medical care. The volume of the sample population formed by random selection amounted to 256 patients of dental profile, 320 therapeutic, 196 surgical (urological), 210 pediatric profile, respectively. An expert assessment of the quality of medical care was carried out according to the methodology that takes into account the implementation of its individual properties, for 984 cases of assistance. It is established that the quality of medical care is reliably influenced by the state of the cultural profile of patients. It was found that the assessment of the patient structural component of the quality of medical services without taking into account their profile was reduced to 40.6% relative to the maximum assessment, especially the characteristics of the sanological and information culture of the patient. The analysis of the role of patient cultural characteristics in the formation of the structural component of the quality of medical services showed the presence among them of characteristics that have a significant impact on the decline in the quality of services. The revealed differences in the value of the relative risk of the same patient cultural risk factor for reducing the quality of medical services in their different profiles substantiated the need to differentiate factors into high-risk and low-risk. The basis for managing the culture of patients should be measures to transform low gradations of cultural characteristics of patients into high ones, through medical information and education, socio-psychological counseling, patient education and the formation of behaviors focused on the preservation and promotion of health.
这项研究的相关性是由于在提供医疗保健的参与者的文化特征方面,改善医疗保健质量的结构组成部分的发展不足。本研究的目的:确定患者文化因素对保证不同类型医疗服务质量的贡献。资料收集采用对原始问卷进行患者社会学调查的方法和对医疗护理案例进行专家评估的方法。随机抽取的样本量分别为牙科256例、治疗320例、外科(泌尿外科)196例、儿科210例。针对984个援助案例,根据考虑到具体情况的方法,对医疗服务质量进行了专家评估。这是确定的,医疗质量是可靠的影响状态的文化档案的病人。研究发现,在不考虑患者概况的情况下,对医疗服务质量的患者结构成分的评估,相对于最高评估,特别是患者的卫生和信息文化特征,减少到40.6%。对患者文化特征在医疗服务质量结构组成部分形成中的作用的分析表明,其中存在对服务质量下降有重大影响的特征。同一患者文化风险因素在不同情况下降低医疗服务质量的相对风险值存在差异,这表明有必要将这些因素区分为高风险和低风险。管理患者文化的基础应该是采取措施,通过医学信息和教育、社会心理咨询、患者教育和形成以维护和促进健康为重点的行为,将患者文化特征的低层次转化为高层次。
{"title":"PATIENT CULTURE AS A FACTOR IN ENSURING THE QUALITY OF MEDICAL CARE","authors":"Oleynik A.V., Mushnikov D.L., Germakhanov Z.Z., Drobysheva E.V.","doi":"10.26787/nydha-2686-6838-2021-23-9-106-112","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-9-106-112","url":null,"abstract":"The relevance of the study is due to the insufficient development of improving the structural component of the quality of medical care in terms of the cultural characteristics of the participants in their provision. The purpose of the study: to determine the contribution of the patient's culture factor to ensuring the quality of medical care of different profiles. The collection of material was carried out by the method of sociological survey of patients on the original questionnaires and the method of expert assessment of cases of medical care. The volume of the sample population formed by random selection amounted to 256 patients of dental profile, 320 therapeutic, 196 surgical (urological), 210 pediatric profile, respectively. An expert assessment of the quality of medical care was carried out according to the methodology that takes into account the implementation of its individual properties, for 984 cases of assistance. It is established that the quality of medical care is reliably influenced by the state of the cultural profile of patients. It was found that the assessment of the patient structural component of the quality of medical services without taking into account their profile was reduced to 40.6% relative to the maximum assessment, especially the characteristics of the sanological and information culture of the patient. The analysis of the role of patient cultural characteristics in the formation of the structural component of the quality of medical services showed the presence among them of characteristics that have a significant impact on the decline in the quality of services. The revealed differences in the value of the relative risk of the same patient cultural risk factor for reducing the quality of medical services in their different profiles substantiated the need to differentiate factors into high-risk and low-risk. The basis for managing the culture of patients should be measures to transform low gradations of cultural characteristics of patients into high ones, through medical information and education, socio-psychological counseling, patient education and the formation of behaviors focused on the preservation and promotion of health.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121654444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
REPRODUCTIVE POTENTIAL OF WOMEN WITH PREMATURE OVARIAN INSUFFICIENCY 卵巢功能不全女性的生殖潜能
Pub Date : 2021-08-30 DOI: 10.26787/nydha-2686-6838-2021-23-8-41-48
Spiridenko G.Yu., Petrov Yu.A., Palieva N.V.
Infertility is currently a priority problem for women of reproductive age. One of the reasons for this condition may be premature ovarian insufficiency. This is a pathological process causes by primary hypogonadism that occurs in women under 40 years of age. Its prevalence varies from 1:10,000 at the age of 20 to 1:100 at an older age. The absence of specific clinical manifestations of the disease complicates its early diagnosis and timely treatment. This pathological process manifests itself as secondary oligo-or amenorrhea, infertility. Less often, before the onset of reproductive disorders, there are manifestations of estrogenic insufficiency - vasomotor disorders - hot flashes, hyperhidrosis, cephalgia, tachycardia, arterial hypertension, emotional and vegetative disorders-irritability, asthenic manifestations, anxiety, depression, hypo - thymia, decreased libido. The lack of accurate data on etiological factors makes it harder to find methods for preventing this disease. The main direction of treatment is hormone replacement therapy, aimed at eliminating the insufficiency of natural estrogens in the woman's body. The chances of successful realization of the reproductive potential depend on the value of the follicle-stimulating hormone, since its high concentration affects the mitotic activity of granulosa cells of the follicle, which confirms the validity of hormone replacement therapy. The non-occurrence of pregnancy after therapy forces the patient to use assisted reproductive technologies using donor embryos and oocytes, while the effectiveness of in vitro fertilization does not exceed 58%. To prevent this outcome, if a woman has risk factors for developing premature ovarian insufficiency, it is necessary to timely assess the ovarian reserve with the preservation of her own oocytes for subsequent assisted reproductive technologies.
不孕不育目前是育龄妇女的一个优先问题。这种情况的原因之一可能是卵巢功能不全。这是一种由原发性性腺功能减退引起的病理过程,发生在40岁以下的女性中。其患病率从20岁时的1:10 000到老年时的1:100不等。该病缺乏特定的临床表现,使其早期诊断和及时治疗复杂化。这种病理过程表现为继发性少经或闭经、不孕症。很少,在生殖障碍发病前,有雌激素功能不全的表现-血管舒缩障碍-潮热,多汗症,头痛,心动过速,动脉高血压,情绪和植物性障碍-易怒,虚弱的表现,焦虑,抑郁,胸腺功能减退,性欲下降。由于缺乏病因的准确数据,因此很难找到预防这种疾病的方法。治疗的主要方向是激素替代疗法,旨在消除女性体内天然雌激素的不足。成功实现生殖潜能的机会取决于促卵泡激素的价值,因为它的高浓度会影响卵泡颗粒细胞的有丝分裂活性,这证实了激素替代疗法的有效性。治疗后未发生妊娠迫使患者使用供体胚胎和卵母细胞辅助生殖技术,而体外受精的有效性不超过58%。为了防止这种结果,如果女性有发生卵巢早衰的危险因素,有必要及时评估卵巢储备,保留自己的卵母细胞,以便后续辅助生殖技术。
{"title":"REPRODUCTIVE POTENTIAL OF WOMEN WITH PREMATURE OVARIAN INSUFFICIENCY","authors":"Spiridenko G.Yu., Petrov Yu.A., Palieva N.V.","doi":"10.26787/nydha-2686-6838-2021-23-8-41-48","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-8-41-48","url":null,"abstract":"Infertility is currently a priority problem for women of reproductive age. One of the reasons for this condition may be premature ovarian insufficiency. This is a pathological process causes by primary hypogonadism that occurs in women under 40 years of age. Its prevalence varies from 1:10,000 at the age of 20 to 1:100 at an older age. The absence of specific clinical manifestations of the disease complicates its early diagnosis and timely treatment. This pathological process manifests itself as secondary oligo-or amenorrhea, infertility. Less often, before the onset of reproductive disorders, there are manifestations of estrogenic insufficiency - vasomotor disorders - hot flashes, hyperhidrosis, cephalgia, tachycardia, arterial hypertension, emotional and vegetative disorders-irritability, asthenic manifestations, anxiety, depression, hypo - thymia, decreased libido. The lack of accurate data on etiological factors makes it harder to find methods for preventing this disease. The main direction of treatment is hormone replacement therapy, aimed at eliminating the insufficiency of natural estrogens in the woman's body. The chances of successful realization of the reproductive potential depend on the value of the follicle-stimulating hormone, since its high concentration affects the mitotic activity of granulosa cells of the follicle, which confirms the validity of hormone replacement therapy. The non-occurrence of pregnancy after therapy forces the patient to use assisted reproductive technologies using donor embryos and oocytes, while the effectiveness of in vitro fertilization does not exceed 58%. To prevent this outcome, if a woman has risk factors for developing premature ovarian insufficiency, it is necessary to timely assess the ovarian reserve with the preservation of her own oocytes for subsequent assisted reproductive technologies.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125104283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE RESURGENCE OF INTRAUTERINE CONTRACEPTION 宫内避孕的复苏
Pub Date : 2021-08-30 DOI: 10.26787/nydha-2686-6838-2021-23-8-34-40
Petrov Yu.A., Spiridenko G.Yu., Bragina T.V.
The topic of intrauterine contraception remains relevant for a very long time. The active search for optimal and safe means of intrauterine contraception began in the last century and is gaining more and more momentum in the modern world. The importance of this issue is due to the continuing need of the population of reproductive age to control childbearing, the popularization of data on various methods of birth control and the desire to use safe, effective, environmentally friendly methods of contraception. The presented topic touches on the aspects of family planning and pre-gravidar training, so it is not only a significant medical, but also a social problem. This leads to the constant need to study new mechanisms of systemic and local effects of intrauterine contraceptives on the female body. This article discusses the use of intrauterine contraceptives, the features of their impact on the endometrium, the reproductive potential of women, as well as the positive and negative aspects of their use. There are also groups of women for whom intrauterine contraception is the method of choice for birth control. The indications for the extraction of an intrauterine contraceptive are described. Among them, there are menstrual disorders of the type of hypermenorrhea lasting more than 6 months in the absence of the effect of the use of non-steroidal anti-inflammatory drugs, the end of the period of use of an intrauterine contraceptive, the desire and need of a woman, the desired pregnancy, expulsions, the postmenopausal period. Knowledge of all aspects of intrauterine contraception allows the obstetrician-gynecologist to correctly select a certain type of IUD, to explain to the woman all the risks of its use, to diagnose and correct complications in a timely manner.
宫内避孕的话题在很长一段时间内仍然是相关的。积极寻求最佳和安全的宫内避孕方法始于上个世纪,并在现代世界获得越来越多的动力。这个问题的重要性是由于育龄人口继续需要控制生育,普及关于各种控制生育方法的数据,以及希望使用安全、有效、无害环境的避孕方法。所提出的主题涉及计划生育和孕前培训方面,因此它不仅是一个重大的医学问题,也是一个社会问题。这导致不断需要研究宫内避孕对女性身体的全身和局部影响的新机制。本文讨论了宫内避孕药具的使用,其对子宫内膜的影响特点,妇女的生殖潜力,以及其使用的积极和消极方面。也有一些妇女选择宫内避孕作为节育的方法。介绍了提取宫内避孕药具的适应症。其中,在使用非甾体抗炎药没有效果的情况下,持续超过6个月的痛经类型,使用宫内避孕药具的期限结束,女性的欲望和需要,期望怀孕,驱逐,绝经后时期。了解宫内避孕的各个方面,使妇产科医生能够正确选择某种类型的宫内节育器,向妇女解释其使用的所有风险,及时诊断和纠正并发症。
{"title":"THE RESURGENCE OF INTRAUTERINE CONTRACEPTION","authors":"Petrov Yu.A., Spiridenko G.Yu., Bragina T.V.","doi":"10.26787/nydha-2686-6838-2021-23-8-34-40","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-8-34-40","url":null,"abstract":"The topic of intrauterine contraception remains relevant for a very long time. The active search for optimal and safe means of intrauterine contraception began in the last century and is gaining more and more momentum in the modern world. The importance of this issue is due to the continuing need of the population of reproductive age to control childbearing, the popularization of data on various methods of birth control and the desire to use safe, effective, environmentally friendly methods of contraception. The presented topic touches on the aspects of family planning and pre-gravidar training, so it is not only a significant medical, but also a social problem. This leads to the constant need to study new mechanisms of systemic and local effects of intrauterine contraceptives on the female body. This article discusses the use of intrauterine contraceptives, the features of their impact on the endometrium, the reproductive potential of women, as well as the positive and negative aspects of their use. There are also groups of women for whom intrauterine contraception is the method of choice for birth control. The indications for the extraction of an intrauterine contraceptive are described. Among them, there are menstrual disorders of the type of hypermenorrhea lasting more than 6 months in the absence of the effect of the use of non-steroidal anti-inflammatory drugs, the end of the period of use of an intrauterine contraceptive, the desire and need of a woman, the desired pregnancy, expulsions, the postmenopausal period. Knowledge of all aspects of intrauterine contraception allows the obstetrician-gynecologist to correctly select a certain type of IUD, to explain to the woman all the risks of its use, to diagnose and correct complications in a timely manner.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115050913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ADVERSE METEOROLOGICAL SITUATION AS A RISK FACTOR FOR CARDIOVASCULAR DISEASES 不利的气象条件是心血管疾病的危险因素
Pub Date : 2021-08-30 DOI: 10.26787/nydha-2686-6838-2021-23-8-28-33
Kolyagina N.M., Berezhnova T.A., Kulintsova Ya.V., Elistratova O.S., Drapalyuk M.A.
Relevance. Exacerbation of the disease, as a rule, leads to the patient seeking medical help. In this regard, data on the population's access to medical care can serve as an indicator of the exacerbation of the disease.Aim: to analyze meteorological risk factors that contribute to the development of cardiovascular diseases.Material and methods. The ratio of the average number of cases of requests for medical care on unfavorable days for meteorological factors to the average number of cases of requests per day for medical care during the year was calculated. Using software tools (STATISTICA Base V6. 1), the type of data distribution was estimated, and a correlation analysis of the likely relationship between the number of medical care requests and the indicators of meteorological factors was carried out.Results. As a result of the study, it was found that the average number of cases of medical care requests on hot days (air temperature over + 300C) is 1.1-1.4 times higher than the average number of cases of requests per day for the same reasons (diagnoses) during the year and is abnormal for the territory of the city of Voronezh, due to such diagnoses as hypertension without heart failure, brain vascular lesions (specified), cerebrovascular disease, hypertension with heart failure.Conclusions. Thus, it was found that one of the meteorological risk factors for the formation of cardiovascular pathology is high air temperature (above + 300C), which is the goal for the implementation of the main directions of prevention of increased weather sensitivity and treatment of weather-dependent patients.
的相关性。通常情况下,病情加重会导致患者寻求医疗帮助。在这方面,关于人口获得医疗保健的数据可以作为疾病恶化的一个指标。目的:分析心血管疾病发生的气象危险因素。材料和方法。计算了在气象因素不利的日子请求医疗护理的平均病例数与一年中每天请求医疗护理的平均病例数的比率。使用软件工具(STATISTICA Base V6)。1)估计了数据分布类型,并对医疗请求次数与气象因素指标之间的可能关系进行了相关分析。作为这项研究的结果,发现医疗服务请求的平均病例数天热时(空气温度超过+ 300 c)是1.1 - -1.4倍的平均数量情况下每天的请求同样的理由(诊断),是不正常的沃罗涅日市境内,由于没有心力衰竭等诊断高血压,大脑血管病变(指定)、脑血管疾病、高血压和心脏failure.Conclusions。由此发现,高气温(+ 300C以上)是心血管病理形成的气象危险因素之一,是防治天气敏感性增高和治疗天气依赖患者的主要方向。
{"title":"ADVERSE METEOROLOGICAL SITUATION AS A RISK FACTOR FOR CARDIOVASCULAR DISEASES","authors":"Kolyagina N.M., Berezhnova T.A., Kulintsova Ya.V., Elistratova O.S., Drapalyuk M.A.","doi":"10.26787/nydha-2686-6838-2021-23-8-28-33","DOIUrl":"https://doi.org/10.26787/nydha-2686-6838-2021-23-8-28-33","url":null,"abstract":"Relevance. Exacerbation of the disease, as a rule, leads to the patient seeking medical help. In this regard, data on the population's access to medical care can serve as an indicator of the exacerbation of the disease.\u0000Aim: to analyze meteorological risk factors that contribute to the development of cardiovascular diseases.\u0000Material and methods. The ratio of the average number of cases of requests for medical care on unfavorable days for meteorological factors to the average number of cases of requests per day for medical care during the year was calculated. Using software tools (STATISTICA Base V6. 1), the type of data distribution was estimated, and a correlation analysis of the likely relationship between the number of medical care requests and the indicators of meteorological factors was carried out.\u0000Results. As a result of the study, it was found that the average number of cases of medical care requests on hot days (air temperature over + 300C) is 1.1-1.4 times higher than the average number of cases of requests per day for the same reasons (diagnoses) during the year and is abnormal for the territory of the city of Voronezh, due to such diagnoses as hypertension without heart failure, brain vascular lesions (specified), cerebrovascular disease, hypertension with heart failure.\u0000Conclusions. Thus, it was found that one of the meteorological risk factors for the formation of cardiovascular pathology is high air temperature (above + 300C), which is the goal for the implementation of the main directions of prevention of increased weather sensitivity and treatment of weather-dependent patients.","PeriodicalId":445713,"journal":{"name":"\"Medical & pharmaceutical journal \"Pulse\"","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129937023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
"Medical & pharmaceutical journal "Pulse"
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1